Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) EBT Margin (2022 - 2023)

Lexeo Therapeutics' EBT Margin history spans 2 years, with the latest figure at 28374.0% for Q4 2023.

  • For Q4 2023, EBT Margin changed N/A year-over-year to 28374.0%; the TTM value through Dec 2023 reached 32387.32%, changed N/A, while the annual FY2024 figure was 71775.91%, 3938860.0% up from the prior year.
  • EBT Margin for Q4 2023 was 28374.0% at Lexeo Therapeutics, down from 38671.15% in the prior quarter.
  • Across five years, EBT Margin topped out at 38671.15% in Q3 2023 and bottomed at 3211.86% in Q3 2022.